Results 241 to 250 of about 170,525 (342)

Harnessing Gut Microbiome–Brain–Liver Crosstalk: Novel Therapeutic Strategies for Metabolic Dysfunction‐Associated Steatotic Liver Disease

open access: yesMedicine Bulletin, EarlyView.
This review reveals the complex mechanisms by which the brain–gut–liver axis (particularly the gut microbiota and its metabolites) drives MASLD, highlighting the therapeutic value of using phages to target and eliminate pathogenic bacteria and their metabolic products.
Xingtao Zhao   +7 more
wiley   +1 more source

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

open access: yesHepatology, 2003
G. Marchesini   +10 more
semanticscholar   +1 more source

Human Cyclophilins—An Emerging Class of Drug Targets

open access: yesMedicinal Research Reviews, EarlyView.
ABSTRACT Cyclophilins are a family of enzymes with peptidyl‐prolyl isomerase activity found in all cells of all organisms. To date, 17 cyclophilin isoforms have been identified in the human body, participating in diverse biological processes. Consequently, cyclophilins have emerged as promising targets for drug development to address a wide array of ...
Katarina Jurkova   +3 more
wiley   +1 more source

Disparities in liver transplantation for metabolic dysfunction-associated steatohepatitis-associated hepatocellular carcinoma. [PDF]

open access: yesWorld J Transplant
Victor DW   +15 more
europepmc   +1 more source

An Integrated Engineering Approach to Creating Health‐Modulating Postbiotics

open access: yesMolecular Nutrition &Food Research, EarlyView.
Postbiotics have emerged as a promising alternative to live probiotics, offering comparable health benefits while overcoming challenges related to safety, stability, and shelf life. The review addresses current challenges in standardizing postbiotic definitions and production processes, and by outlining future research directions necessary to unlock ...
Michael Leonidas Chikindas   +10 more
wiley   +1 more source

Supervised learning reveals circulating biomarker levels diagnostic of hepatocellular carcinoma in a clinically relevant model of non-alcoholic steatohepatitis; An OAD to NASH

open access: gold, 2018
Anne Hwang   +17 more
openalex   +2 more sources

Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates

open access: yesClinical Gastroenterology and Hepatology, 2019
Z. Younossi   +16 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy